Overview

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This trial will compare the efficacy of docetaxel versus vinorelbine as first-line treatment in elderly patients with advanced NSCLC.
Phase:
Phase 3
Details
Lead Sponsor:
Hellenic Oncology Research Group
Collaborator:
University Hospital of Crete
Treatments:
Docetaxel
Vinblastine
Vinorelbine